Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study

  1. Buske, C.
  2. Tedeschi, A.
  3. Trotman, J.
  4. García-Sanz, R.
  5. MacDonald, D.
  6. Leblond, V.
  7. Mahe, B.
  8. Herbaux, C.
  9. Matous, J.V.
  10. Tam, C.S.
  11. Heffner, L.T.
  12. Varettoni, M.
  13. Palomba, M.L.
  14. Shustik, C.
  15. Kastritis, E.
  16. Treon, S.P.
  17. Ping, J.
  18. Hauns, B.
  19. Arango-Hisijara, I.
  20. Dimopoulos, M.A.
Revista:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Any de publicació: 2022

Volum: 40

Número: 1

Pàgines: 52-62

Tipus: Article

DOI: 10.1200/JCO.21.00838 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible